BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19139082)

  • 1. Cognate CD4 help is essential for the reactivation and expansion of CD8 memory T cells directed against the hematopoietic cell-specific dominant minor histocompatibility antigen, H60.
    Ryu SJ; Jung KM; Yoo HS; Kim TW; Kim S; Chang J; Choi EY
    Blood; 2009 Apr; 113(18):4273-80. PubMed ID: 19139082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others.
    Choi EY; Yoshimura Y; Christianson GJ; Sproule TJ; Malarkannan S; Shastri N; Joyce S; Roopenian DC
    J Immunol; 2001 Apr; 166(7):4370-9. PubMed ID: 11254691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subdominant H60 antigen-specific CD8 T-cell response precedes dominant H4 antigen-specific response during the initial phase of allogenic skin graft rejection.
    Yoo KI; Jeon JY; Ryu SJ; Nam G; Youn H; Choi EY
    Exp Mol Med; 2015 Feb; 47(2):e140. PubMed ID: 25676063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection.
    Shedlock DJ; Whitmire JK; Tan J; MacDonald AS; Ahmed R; Shen H
    J Immunol; 2003 Feb; 170(4):2053-63. PubMed ID: 12574376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCR diversity of H60-specific CD8 T cells during the response evolution and influence of CD4 help.
    Choi JH; Ryu SJ; Jung KM; Kim S; Chang J; Kim TW; Choi EY
    Transplantation; 2009 Jun; 87(11):1609-16. PubMed ID: 19502951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression.
    Honey K; Cobbold SP; Waldmann H
    J Immunol; 1999 Nov; 163(9):4805-10. PubMed ID: 10528180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4(+)and CD8(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT.
    Steger B; Milosevic S; Doessinger G; Reuther S; Liepert A; Braeu M; Schick J; Vogt V; Schuster F; Kroell T; Busch DH; Borkhardt A; Kolb HJ; Tischer J; Buhmann R; Schmetzer H
    Immunobiology; 2014 Apr; 219(4):247-60. PubMed ID: 24315637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of functional CD8 T cell memory after Listeria monocytogenes infection is not dependent on CD40.
    Montfort MJ; Bouwer HG; Wagner CR; Hinrichs DJ
    J Immunol; 2004 Sep; 173(6):4084-90. PubMed ID: 15356158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells.
    Lefrançois L; Altman JD; Williams K; Olson S
    J Immunol; 2000 Jan; 164(2):725-32. PubMed ID: 10623816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Listeria monocytogenes infection overcomes the requirement for CD40 ligand in exogenous antigen presentation to CD8(+) T cells.
    Hamilton SE; Tvinnereim AR; Harty JT
    J Immunol; 2001 Nov; 167(10):5603-9. PubMed ID: 11698431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognate memory CD4+ T cells generated with dendritic cell priming influence the expansion, trafficking, and differentiation of secondary CD8+ T cells and enhance tumor control.
    Hwang ML; Lukens JR; Bullock TN
    J Immunol; 2007 Nov; 179(9):5829-38. PubMed ID: 17947656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells.
    Bullock TN; Yagita H
    J Immunol; 2005 Jan; 174(2):710-7. PubMed ID: 15634890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
    Ito H; Kurtz J; Shaffer J; Sykes M
    J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-pulsed splenic dendritic cells prime long-lasting CD8(+) T cell memory in the absence of cross-priming by host APC.
    Livingstone AM; Kuhn M
    Eur J Immunol; 2002 Jan; 32(1):281-90. PubMed ID: 11782019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
    van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
    J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells.
    Gorbacheva V; Ayasoufi K; Fan R; Baldwin WM; Valujskikh A
    Am J Transplant; 2015 Feb; 15(2):346-57. PubMed ID: 25496308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell subsets required for in vivo and in vitro responses to single and multiple minor histocompatibility antigens.
    Wettstein PJ; Korngold R
    Transplantation; 1992 Aug; 54(2):296-307. PubMed ID: 1353915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation.
    Kwun J; Malarkannan S; Burlingham WJ; Knechtle SJ
    J Immunol; 2011 Oct; 187(8):3997-4006. PubMed ID: 21900176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.
    Chen Y; Heeger PS; Valujskikh A
    J Immunol; 2004 May; 172(9):5456-66. PubMed ID: 15100287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.